2-Amino-3-(thiophen-2-yl)propan-1-ol hydrochloride, 5g

Ethyl 2-Aminoisonicotinate>98.0%(GC)(T)1g

1,3-butanediol, min. 99%, for synthesis, 10 l, plastic packaging.

1-Methyl-1,2,3,4-tetrahydroquinoxaline, 95+%, 5g

(1-Phenylcyclopentyl)methanol, 98%, 5g

3-Bromo-1H-indazol-7-amine, 95.0%, 250mg

Anthracene, 9,9',9''-(1,3,5-benzenetriyl)tris[10-bromo-, 95%, 5g

5-Hydroxyisobenzofuran-1,3-dione, 95.0%, 250mg

2-Bromo-6-fluoro-3-propoxybenzaldehyde, 98%, 1g

Methyl 2-amino-4-isobutylthiophene-3-carboxylate, 95%, 25g

7-Amino-2-benzoxazolinone>95.0%(GC)(T)250mg

5-BROMO-2-(2-(TRIMETHYLSILYL)ETHYNYL)PYRIDINE, 95.0%, 1g

Gemcitabine hydrochloride, 98.0%, 50g